معرفی
Ify Mordi, PhD, serves as a Clinical Senior Lecturer and Honorary Consultant in Teaching and Research within the Division of Cardiovascular Research at the University of Dundee's School of Medicine. With an impressive research portfolio spanning over a decade, Dr. Mordi has published 139 research outputs and secured significant funding from organizations including the British Heart Foundation and Juvenile Diabetes Research Foundation. Her work contributes to UN Sustainable Development Goals related to good health and well-being through innovative cardiovascular research.
Dr. Mordi's research focuses on the intersection of cardiovascular disease and diabetes, with particular expertise in heart failure (especially heart failure with preserved ejection fraction), aortic stenosis, and coronary artery disease. Her work increasingly incorporates artificial intelligence applications in cardiovascular medicine, including groundbreaking research using retinal imaging to predict cardiovascular outcomes. She leads multiple major research initiatives including the SOPHIST trial investigating Sotagliflozin in patients with heart failure symptoms and type 1 diabetes, and the UK HFpEF Registry in collaboration with the University of Manchester.
Analysis of Dr. Mordi's recent publications reveals a strong trend toward integrating advanced analytics and AI with traditional cardiovascular research. Her work spans genetic epidemiology, clinical trials, population health studies, and innovative diagnostic approaches. The research demonstrates growing emphasis on precision medicine approaches for cardiovascular disease, particularly in diabetic populations, and the development of non-invasive diagnostic tools that could transform clinical practice.
Dr. Mordi actively contributes to academic mentoring through PhD examinations and serves as an invited speaker at international conferences. Her research has received significant media attention, with coverage in 13 news outlets and mentions across social media platforms, highlighting the translational impact of her work. She has been involved in multiple high-impact collaborative projects including the iDiabetes Platform for enhanced phenotyping of diabetes patients and the REACH-HFpEF study examining home-based rehabilitation for heart failure patients.
Through her leadership in the British Heart Foundation-funded Clinical Fellowship focused on improving prediction and prevention of heart failure in type 1 diabetes, Dr. Mordi is establishing herself as a key investigator in the field of cardio-diabetology. Her research program bridges basic science, clinical application, and health services research to address critical gaps in cardiovascular care for diabetic patients.
